In an upcoming live broadcast, John Mascarenhas, MD, PhD, Srdan Verstovsek, MD, PhD, James McCloskey, MD, and Jeanne Palmer, MD will guide presentation and Q&A on the management of cytopenic myelofibrosis. The broadcast will feature a discussion about the underlying factors and phenotypes of the disease, the current treatment landscape and unmet needs, as well as an exploration of the safety, efficacy, and dosing of a new treatment option.
To learn about the changing treatment spectrum for cytopenic myelofibrosis, watch the live broadcast on March 31, 2022 at 7pm ET and 9pm ET. To register for the event, visit https://www.webcasteventregistration.com/ctibiopharma_cytopenic_MF_broadcast.
© 2022 CTI BioPharma Corp. US-PAC-2100098 03/2022